Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Phase I/IIa Study of Intravenous BAL101553 in Adult Patients With Advanced Solid Tumors

NCT01397929 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT01397929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01397929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Phase I/IIa Study of Intravenous BAL101553 in Adult Patients With Advanced Solid Tumors
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2011
Completion date
April 30, 2016
Enrollment
73 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid organ tumors